Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5524.00 | 5451.00 | 1.0134 | 1.0358 |
| SK-BR-3 | Nilotinib | 10 | uM | 4 | 5000.00 | 3240.08 | 2081.00 | 5451.00 | 0.3818 | -0.4456 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5570.00 | 5451.00 | 1.0218 | 1.0584 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 4 | 5000.00 | 3240.08 | 1890.00 | 5451.00 | 0.3467 | -0.5124 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5493.00 | 5451.00 | 1.0077 | 1.0206 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5373.00 | 5451.00 | 0.9857 | 0.9620 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5242.00 | 5451.00 | 0.9617 | 0.8985 | |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5198.00 | 5451.00 | 0.9536 | 0.8773 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 5000.00 | 3240.08 | 2353.00 | 5451.00 | 0.4317 | -0.3471 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 4 | 5000.00 | 3240.08 | 5538.00 | 5451.00 | 1.0160 | 1.0426 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5742.00 | 5451.00 | 1.0534 | 1.1435 | |
| SK-BR-3 | NVP-TAE684 | 10 | uM | 4 | 5000.00 | 3240.08 | 2543.00 | 5451.00 | 0.4665 | -0.2759 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5610.00 | 5451.00 | 1.0292 | 1.0781 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 5000.00 | 3240.08 | 5786.00 | 5451.00 | 1.0615 | 1.1654 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5595.00 | 5451.00 | 1.0264 | 1.0707 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 4 | 5000.00 | 3240.08 | 5575.00 | 5451.00 | 1.0227 | 1.0609 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 5000.00 | 3240.08 | 5556.00 | 5451.00 | 1.0193 | 1.0515 |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 5000.00 | 3240.08 | 5241.00 | 5451.00 | 0.9615 | 0.8980 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 5000.00 | 3240.08 | 5950.00 | 5451.00 | 1.0915 | 1.2476 |
| SK-BR-3 | 0 | uM | 4 | 5000.00 | 3240.08 | 5567.00 | 5451.00 | 1.0213 | 1.0569 | |
| SK-BR-3 | PLX-4720 | 19.9526 | uM | 4 | 5000.00 | 3240.08 | 4920.00 | 5451.00 | 0.9026 | 0.7447 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5569.00 | 5451.00 | 1.0216 | 1.0579 |
| SK-BR-3 | Nilotinib | 1 | uM | 4 | 5000.00 | 3240.08 | 5649.00 | 5451.00 | 1.0363 | 1.0974 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 5000.00 | 3240.08 | 5752.00 | 5451.00 | 1.0552 | 1.1485 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 4 | 5000.00 | 3240.08 | 5752.00 | 5451.00 | 1.0552 | 1.1485 |